AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2021

Nov 1, 2021

32566_dirs_2021-11-01_ae166d3c-3d8e-4208-aa71-490625a521fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-04-01

Reporting Person: Lambert Nicole (President, MGL)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25830	Direct

Footnotes

F1: 317 shares of Myriad common stock were inadvertently omitted from the reporting person's original Form 3, and also were omitted from 15 Form 4's filed by the reporting person after her original Form 3 was filed.